Document:

Exhibit 4.1 

 

DESCRIPTION OF THE REGISTRANT’S SECURITIES

REGISTERED PURSUANT TO SECTION 12 OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Clearfield, Inc. (“Clearfield,” “we,” “our,”
or “us”) has one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended:
our common stock.

 

DESCRIPTION OF CAPITAL STOCK

 

The following summary of the general terms and provisions of our
capital stock does not purport to be complete and is based upon and qualified by reference to our articles of incorporation and
bylaws, which are filed as exhibits to our Annual Report on Form 10-K and are incorporated by reference herein. We encourage you
to read our articles of incorporation, our bylaws and the applicable provisions of the Minnesota Business Corporation Act, or MBCA,
for additional information.

 

Authorized Shares of Capital Stock

 

The aggregate number of shares of capital stock that the Company
has authority to issue is 55,000,000 shares, which consists of 50,000,000 shares of common stock, par value $0.01, and 5,000,000
undesignated shares, par value $0.01 per share.

 

Common Stock

 

Holders of the Company’s common stock are entitled to one
vote for each share held of record on all matters submitted to a vote of the shareholders and do not have cumulative voting rights.
Except as otherwise provided by law, our articles of incorporation or our bylaws, matters will generally be decided by the vote
of the holders of a majority of the voting power present in person or represented by proxy. Our bylaws provide that the authorized
number of directors shall be fixed from time to time by a resolution of the board of directors. Our board of directors is not classified.

 

Holders of our common stock are entitled to receive dividends declared
by our board of directors out of funds legally available for the payment of dividends, subject to the rights, if any, of preferred
shareholders. In the event of any liquidation, dissolution or winding-up of our affairs, holders of common stock will be entitled
to share ratably in our assets that are remaining after payment or provision for payment of all of our debts and obligations and
the liquidation preferences of outstanding shares of preferred stock, if any.

 

Holders of common stock have no preemptive, conversion or subscription
rights, and there are no redemption provisions applicable to the common stock.

 

All outstanding shares of our common stock are fully paid and non-assessable.

 

The rights, preferences and privileges of the holders of common
stock are subject to, and may be adversely affected by, the rights of the holders of shares of any series of preferred stock that
we may designate in the future.

 

The transfer agent and registrar for our common stock is Equiniti
Trust Company.

 

Our common stock is currently listed on The NASDAQ Stock Market
LLC under the trading symbol “CLFD.”

 

     

     

    

 

Preferred Stock

 

From the 5,000,000 undesignated shares of capital stock, 500 shares
have been designated as 2% Series A Convertible Preferred Stock and 500,000 shares have been designated as Series B Junior Participating
Preferred Shares. On July 18, 2000, the Company redeemed all 500 authorized and then issued shares of the 2% Series A Convertible
Preferred Stock. The shares of 2% Series A Convertible Preferred Stock redeemed were cancelled and may not be reissued. No shares
of Series B Junior Participating Preferred Shares are outstanding. The Series B Junior Participating Preferred Shares are summarized
below under “Anti-Takeover Effects of Provisions of our Articles of Incorporation, our Bylaws and Minnesota Law.”

 

Under Clearfield’s articles of incorporation, our board of
directors may, from time to time, establish by resolution from the undesignated shares different classes or series of shares and
may fix the relative rights and preferences of said shares in any class or series. The Company’s board of directors has further
authority to issue shares of the common stock to the holders of shares of the common stock and to the holder of any class or series
of the undesignated shares and it may issue shares of any class or series of the undesignated shares to the holders of shares of
the common stock and to the holder of any class or series of the undesignated shares, in any case, for any purpose.

 

Anti-Takeover Effects of Provisions of our Articles of Incorporation,
our Bylaws and Minnesota Law

 

Certain provisions of Minnesota law, our articles of incorporation
and our bylaws may be deemed to have an anti-takeover effect.

 

Series B Junior Participating Preferred Shares

 

On November 3, 2000, our board of directors adopted resolutions
creating a series of preferred stock, par value $0.01 per share, designated as the Series B Junior Participating Preferred Shares
and authorizing 500,000 shares as constituting the Series B Junior Participating Preferred Shares. The Series B Junior Participating
Preferred Shares were created in connection with our shareholder rights plan which expired on November 13, 2010.

 

Under the shareholder rights plan when it was in effect, if any
person or group (the “Acquiring Person”) became the beneficial owner of 15% or more of our outstanding common stock,
all other holders of our common stock would be entitled to purchase from us 1/100 of a Series B Junior Participating Preferred
Share at a price of $80 per 1/100 of a Preferred Share, subject to adjustment. In the event that any person or group became an
Acquiring Person, each holder of this Preferred Share purchase right, other than rights that are or were beneficially owned by
the Acquiring Person (which would thereafter be void), would thereafter have the right to receive, upon exercise thereof at the
then current exercise price of the right, that number of shares of our common stock having a market value of two times the exercise
price of the right. The effect of the shareholder rights plan was to dilute the Acquiring Person thereby making the cost of abusive
unsolicited takeover practices prohibitive and create an incentive for a potential acquiror to negotiate in good faith with our
board of directors.

 

Although the shareholder rights plan expired on November 13, 2010,
our board of directors has the right to reinstate the shareholder rights plan or adopt a new shareholder rights plan without shareholder
approval.

 

The resolutions creating the Series B Junior Participating Preferred
Shares provide that the holders of Series B Junior Participating Preferred Shares are entitled, in preference to holders of common
stock, to quarterly dividends when, if and as declared by our board of directors in an amount equal to the greater of $1 per share
or 100 times the dividend declared per share of common stock whenever such dividend is declared. In the event of liquidation, the
holders of Series B Junior Participating Preferred Shares will be entitled to the greater of a minimum preferential liquidation
payment of $100 per share or aggregate payment of 100 times the payment made per share of common stock. Each Series B Junior Participating
Preferred Share will have 100 votes, voting together with common stock. In the event of any merger, consolidation or other transaction
in which shares of common stock are exchanged, each Series B Junior Participating Preferred Share will be entitled to receive 100
times the amount received per share of common stock. These rights will be protected by customary anti-dilution provisions. Series
B Junior Participating Preferred Shares are not redeemable.

 

     

     

    

 

Designation of Capital Stock

 

The ability of our board of directors to designate classes or series
of stock from our authorized stock makes it possible for our board of directors to issue preferred stock with voting or other rights
or preferences that could impede the success of any attempt to change control of us. These provisions may have the effect of deterring
hostile takeovers or delaying changes in control or management of our company.

 

Shareholder Meetings

 

Under our bylaws, annual meetings of our shareholders may be called
only by our board of directors.

 

Under our bylaws, special meetings of our shareholders may be held
at any time and for any purpose and may be called by the chief executive officer, chief financial officer, any two directors, or
by a shareholder or shareholders holding 10% or more of the voting power of all shares entitled to vote on the matters to be presented
to the meeting, except that a special meeting for the purpose of considering any action to directly or indirectly effect a business
combination, including any action to change or otherwise affect the composition of the board of directors for that purpose, must
be called by 25% or more of the voting power of all shares entitled to vote.

 

Requirements for Advance Notification of
Shareholder Nominations and Proposals

 

Nominations for election to our board of directors may be made by
the board of directors or a committee appointed by the board of directors or by any shareholder entitled to vote generally in the
election of directors who follows the advance notice procedures described in Section 2. 14-a of our bylaws. In general, a shareholder
must submit a written notice of the nomination to our principal executive office not less than 90 days nor more than 120 days prior
to the first anniversary of the date on which we first mailed our proxy materials for the preceding year’s annual meeting
of shareholders, together with required information regarding the shareholder and each person the shareholder proposes to nominate.

 

Shareholders can propose business, other than nominations to our
board of directors, to be considered at an annual meeting of shareholders only if a shareholder follows the advance notice procedures
described in Section 2. 14-b of our bylaws. In general, a shareholder must submit a written notice of the proposal together with
required information regarding the shareholder and the shareholder’s interest in the proposal to our corporate secretary
not less than 90 days nor more than 120 days prior to the first anniversary of the date on which we first mailed our proxy materials
for the preceding year’s annual meeting of shareholders.

 

Unanimous Shareholder Action in Writing

 

Our bylaws permit shareholders to take any action that might be
taken at a meeting of the shareholders by written action, but only if it is signed by all of the shareholders entitled to vote
on that action.

 

Provisions of Minnesota Law

 

The following provisions of the MBCA may have an effect of delaying,
deterring or preventing an unsolicited takeover of the Company or make an unsolicited takeover of the Company more difficult.

 

     

     

    

 

In general, Section 302A.553 of the MBCA prohibits a publicly
held corporation, such as Clearfield, from purchasing shares entitled to vote for more than market value from a person that beneficially
owns more than 5% of the voting power of the corporation if the shares have been beneficially owned for less than two years unless
the purchase or agreement to purchase is approved at a meeting of shareholders by the affirmative vote of the holders of a majority
of the voting power of all shares entitled to vote or the corporation makes an offer, of at least equal value per share, to all
shareholders for all other shares of that class or series and any other class or series into which they may be converted.

 

In general, Section 302A.671 of the MBCA provides that
shares of an “issuing public corporation,” such as Clearfield, acquired by an “acquiring person” in a “control
share acquisition” that exceed the threshold of voting power of any of the three ranges identified below will not have voting
rights, unless the issuing public company’s shareholders vote to accord such shares the voting rights normally associated
with such shares. A “control share acquisition” is an acquisition, directly or indirectly, by an “acquiring person”
(as defined in the MBCA) of beneficial ownership of shares of an issuing public corporation that, but for Section 302A.671, would,
when added to all other shares of the issuing public corporation beneficially owned by the acquiring person, entitle the acquiring
person, immediately after the acquisition, to exercise or direct the exercise of a new range of voting power of the issuing public
corporation with any of the following three ranges: (i) at least 20 percent but less than 33-1/3 percent; (ii) at least 33-1/3
percent but less than or equal to 50 percent; and (iii) over 50 percent. The issuing public company also has an option to call
for redemption all, but not less than all, shares acquired in the control share acquisition that exceed the threshold of voting
power of any of the specified ranges at a price equal to the fair market value of the shares at the time the call is given if (i)
the acquiring person fails to deliver the information statement to the issuing public company by the tenth day after the control
share acquisition; or (ii) shareholders have voted not to accord voting rights to the shares acquired in the control share acquisition.

 

In general, Section 302A.673 of the MBCA prohibits a public
Minnesota corporation, such as Clearfield, from engaging in a business combination with an interested shareholder for a period
of four years after the date of the transaction in which the person became an interested shareholder, unless either the business
combination or the acquisition by which such person becomes an interested shareholder is approved in a prescribed manner before
the person became an interested shareholder. The term “business combination” includes mergers, asset sales and other
transactions resulting in a financial benefit to the interested shareholder. An “interested shareholder” is a person
who is the beneficial owner, directly or indirectly, of 10% or more of a corporation’s voting stock, or who is an affiliate
or associate of the corporation, and who, at any time within four years before the date in question, was the beneficial owner,
directly or indirectly, of 10% or more of the corporation’s outstanding voting stock.

 

If a takeover offer is made for our stock, Section 302A.675
of the MBCA precludes the offeror from acquiring additional shares of stock (including in acquisitions pursuant to mergers, consolidations
or statutory share exchanges) within two years following the completion of the takeover offer, unless shareholders selling their
shares in the later acquisition are given the opportunity to sell their shares on terms that are substantially the same as those
contained in the earlier takeover offer. A “takeover offer” is a tender offer which results in an offeror who owned
ten percent or less of a class of our shares acquiring more than ten percent of that class, or which results in the offeror increasing
its beneficial ownership of a class of our shares by more than ten percent of the class, if the offeror owned ten percent or more
of the class before the takeover offer. Section 302A.675 does not apply if a committee of our board of directors formed in accordance
with Section 302A.675 approves the proposed acquisition before any shares are acquired pursuant to the earlier tender offer.Exhibit

Exhibit 10.1

SECOND AMENDMENT TO CREDIT AGREEMENT

This Second Amendment to Credit Agreement (“Amendment”) dated November 15, 2019 is entered into between DAKTRONICS, INC., a South Dakota corporation (the “Borrower”) and U.S. BANK NATIONAL ASSOCIATION, a national banking association (together with its successors and assigns, the “Lender”).  
RECITALS:

A.Lender and Borrower entered into a Credit Agreement dated November 15, 2016, as amended, pursuant to which Lender made certain Revolving Loans to Borrower. 

B.The parties wish to amend the Credit Agreement as provided in this Amendment.

NOW, THEREFORE, for good and valuable consideration, the receipt of which is acknowledged, the parties agree as follows:

1.The following defined term is added to Section 1.1 of the Credit Agreement:

“Laws” means collectively, all international, foreign, federal, state and local statutes, treaties, rules, guidelines, regulations, ordinances, codes and administrative or judicial precedents or authorities such as orders, writs, judgments, injunctions, decrees or awards, including the interpretation or administration thereof by any Governmental Authority charged with the enforcement, interpretation or administration thereof, and all applicable administrative orders, directed duties, requests, licenses, authorizations and permits of, and agreements with, any Governmental Authority, in each case whether or not having the force of law.
2.The following defined terms in Section 1.1 of the Credit Agreement are amended and restated to read:

“Change in Law” means the occurrence, after the date of this Agreement, of any of the following:  (a) the adoption or taking effect of any law, rule, regulation or treaty, (b) any change in any law, rule, regulation or treaty or in the administration, interpretation, implementation or application thereof by any Governmental Authority or (c) the making or issuance of any request, rule, guideline or directive (whether or not having the force of law) by any Governmental Authority; provided that, notwithstanding anything herein to the contrary, (x) the Dodd-Frank Wall Street Reform and Consumer Protection Act and all requests, rules, guidelines or directives thereunder or issued in connection therewith and (y) all requests, rules, guidelines or directives promulgated by the Bank for International Settlements, the Basel Committee on Banking Supervision (or any successor or similar authority) or the United States or foreign regulatory authorities, in each case pursuant to Basel III, shall in each case be deemed to be a “Change in Law,” regardless of the date enacted, adopted or issued.

“Facility Termination Date” means November 15, 2022, or any earlier date on which the Revolving Commitment Amount is reduced to zero or the Revolving Commitment is otherwise terminated pursuant to the terms hereof.
“Sanctions” means sanctions administered or enforced from time to time by the U.S. government, including those administered by OFAC or the U.S. Department of State, the United Nations Security Council, the European Union, Her Majesty’s Treasury or other relevant sanctions authority.

1

3.The following defined terms are deleted from Section 1.1 of the Loan Agreement: “Risk Based Capital Guidelines,” “Sanctioned Country,” and “Sanctioned Person.” 

4.Section 2.6 of the Credit Agreement is amended and restated to read:

2.6    Interest Rates. Interest on each advance hereunder shall accrue at an annual rate equal to the Applicable Margin plus the Daily Reset LIBOR Rate. Lender’s internal records of applicable interest rates shall be determinative in the absence of manifest error. If the rate index described above shall become unavailable or shall cease to exist, Lender may, in its discretion, designate a successor to the interest rate described above (which may include a successor index and a spread adjustment). 
5.Section 3.1 of the Credit Agreement is amended and restated to read:

3.1    Yield Protection; Capital Adequacy.

(a)Increased Costs Generally.  If any Change in Law shall:

(i)impose, modify or deem applicable any reserve, special deposit, compulsory loan, insurance charge or similar requirement against assets of, deposits with or for the account of, or credit extended or participated in by, Lender;

(ii)subject Lender to any Taxes (other than Indemnified Taxes, Excluded Taxes, and Other Taxes) on its loans, loan principal, letters of credit, commitments, or other obligations, or its deposits, reserves, other liabilities or capital attributable thereto, or

(iii)impose on Lender or the London interbank market any other condition, cost or expense (other than Taxes) affecting this Agreement or a Loan, and the result of any of the foregoing is to increase the cost to Lender of making, converting to, continuing or maintaining any Loan or of maintaining its obligation to make any Loan or to reduce the amount of any sum received or receivable by Lender hereunder (whether of principal, interest or any other amount), then, upon request of Lender, Borrower will pay to Lender such additional amount or amounts as will compensate Lender for such additional costs incurred or reduction suffered.

(b)Capital Requirements. If Lender determines that any Change in Law affecting Lender or any lending office of Lender or Lender’s holding company, if any, regarding capital or liquidity requirements, has or would have the effect of reducing the rate of return on Lender’s capital or on the capital of Lender’s holding company, if any, as a consequence of this Agreement, the Revolving Commitment or the Loans to a level below that which Lender or Lender’s holding company could have achieved but for such Change in Law (taking into consideration Lender’s policies and the policies of Lender’s holding company with respect to capital adequacy), then from time to time Borrower will pay to Lender such additional amount or amounts as will compensate Lender or Lender’s holding company for any such reduction suffered.

		
	6.
	Section 3.2 of the Credit Agreement is amended and restated to read:

2

3.2     Certificates for Reimbursement; Delay in Requests. A certificate of Lender setting forth the amount or amounts necessary to compensate Lender or its holding company, as the case may be, as specified in Section 3.1 and delivered to Borrower shall be conclusive absent manifest error.  Borrower shall pay Lender the amount shown as due on any such certificate within 10 days after receipt thereof. Failure or delay on the part of Lender to demand compensation pursuant to Section 3.1 shall not constitute a waiver of Lender’s right to demand such compensation; provided that Borrower shall not be required to compensate Lender pursuant to Section 3.1 for any increased costs incurred or reductions suffered more than nine months prior to the date that Lender notifies Borrower of the Change in Law giving rise to such increased costs or reductions, and of Lender’s intention to claim compensation therefor (except that, if the Change in Law giving rise to such increased costs or reductions is retroactive, then the nine-month period referred to above shall be extended to include the period of retroactive effect thereof).

		
	7.
	Section 5.17 of the Credit Agreement is amended and restated to read:

5.17    Anti-Corruption Laws; Sanctions; Anti-Terrorism Laws. Borrower, its Subsidiaries and their respective officers and employees and to the knowledge of Borrower, their respective directors and agents, are in compliance with Anti-Corruption Laws and applicable Sanctions in all material respects.  Borrower has implemented and maintains in effect for itself and its Subsidiaries policies and procedures to ensure compliance by Borrower, its Subsidiaries, and their respective officers, employees, directors, and agents with Anti-Corruption Laws and applicable Sanctions.  None of Borrower, its Subsidiaries or any directors, officer, employee, agent, or affiliate of Borrower or its Subsidiaries is an individual or entity that is, or is 50% or more owned (individually or in the aggregate, directly or indirectly) or controlled by individuals or entities (including any agency, political subdivision or instrumentality of any government) that are (i) the target of any Sanctions or (ii) located, organized or resident in a country or territory that is, or whose government is, the subject of Sanctions (currently Crimea, Cuba, Iran, North Korea and Syria).

		
	8.
	Section 6.2 of the Credit Agreement is amended and restated to read:

6.2    Using Loan Proceeds.  Borrower will not request any Loan, and will not use, and Borrower will ensure that its Subsidiaries and its or their respective directors, officers, employees and agents do not use, the proceeds of any Loan in furtherance of an offer, payment, promise to pay, or authorization of the payment or giving of money, or anything else of value, to any Person in violation of any Anti-Corruption Laws.  Borrower will not, directly or indirectly, use the proceeds of the Loans, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture partner or other Person, (i) to fund any activities or business of or with any Person, or in any country or territory, that, at the time of such funding, is, or whose government is, the subject of Sanctions, or (ii) in any other manner that would result in a violation of Sanctions by any Person (including any Person participating in the Loans, whether as underwriter, advisor, investor, or otherwise).

		
	9.
	Section 6.7 of the Credit Agreement is amended and restated to read:

6.7    Compliance with Laws; Anti-Money Laundering Laws.

(a)Borrower will, and will cause its Subsidiaries to, (i) comply in all material respects with all Laws to which it may be subject including, without limitation, Anti-Corruption Laws and applicable Sanctions, and (ii) perform in all material respects their obligations under material agreements to which they are a party. Borrower will maintain in effect and enforce policies and procedures designed to ensure compliance by Borrower, its Subsidiaries, and their respective directors, officers, employees and agents 

3

with Anti-Corruption Laws and applicable Sanctions. Borrower will not use or allow any tenants or subtenants to use, or permit any Subsidiary to use or allow any tenants or subtenants to use any Property owned by Borrower for any business activity that violates any federal or state law or that supports a business that violates any federal or state law.

(b)Borrower will, and will cause its Subsidiaries and Affiliates to, provide such information and take such actions as are reasonably requested by Lender in order to assist Lender in maintaining compliance with any anti-money laundering Laws.

		
	10.
	Section 6.16 of the Credit Agreement is amended and restated to read:

6.16    Financial Covenants.
(a)Adjusted Fixed Charge Coverage Ratio. Borrower will not permit the Adjusted Fixed Charge Ratio, determined as of the end of each fiscal quarter for the then most-recently ended four (4) fiscal quarters, to be less than 2.0 to 1.0.

(b)IBD/EBITDA Ratio.  Borrower will not permit the ratio of its IBD to EBITDA, determined as of the end of each fiscal quarter for the then most-recently ended four (4) fiscal quarters, to be greater than 2.0 to 1.0. 
 
11.    Borrower represents and warrants that as of the date of this Amendment, no Default or Event of Default has occurred and is continuing. 
 
12.    This Amendment does not constitute a novation of the Credit Agreement.  Except as modified in this Amendment, all of the terms and conditions of the Credit Agreement will remain in full force and effect.

13.    Borrower acknowledges the Credit Agreement and related Loan Documents are and will remain the legal and binding obligation of Borrower, free of any claim, defense, or offset.

14.    The officers signing on behalf of the Borrower represent and warrant that the execution and delivery of this Amendment has been fully authorized by all necessary corporate action.    

4

	
			
	 
	BORROWER:

DAKTRONICS, INC.

By: /s/ Reece A. Kurtenbach
Name: Reece A. Kurtenbach
Title: Chief Executive Officer

By: /s/ Sheila M. Anderson
Name: Sheila M. Anderson
Title: Chief Financial Officer

	 
	 

	 
	LENDER:

U.S. BANK NATIONAL ASSOCIATION

By: /s/ Carl A. Johnson
Name: Carl A. Johnson
Title: Vice President

5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00302-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00302-of-00352.parquet"}]]